GLP-1 weight loss claims on TikTok: separating signal from noise

What did @lisamleone3 actually say?

The video is pretty light on medical claims. @lisamleone3 is essentially narrating a food decision in real time, debating between chicken shrimp, a cheesy burrito, and sushi, and landing on "treat yourself" as the conclusion. There is no explicit GLP-1 advice, no dosing guidance, no before-and-after framing. What the video does do, whether intentionally or not, is show someone openly deliberating over food choices and landing on indulgence. In the context of a GLP-1-tagged post with 183,600 views, that framing carries implicit meaning for a lot of viewers who are on these medications and wondering how to think about food freedom.

That implicit message, that it is okay to crave food and eat what you want even on GLP-1 therapy, is actually more interesting to examine than anything the creator said out loud.

Does the science back this up?

Here is where it gets genuinely interesting. GLP-1 receptor agonists like semaglutide and tirzepatide are well-documented to reduce appetite and food noise, but they do not eliminate cravings entirely, and they are not designed to put someone in a state of dietary perfection. The idea that you still want sushi or a burrito while on a GLP-1 is not a failure of the drug. It is normal physiology.

Blundell et al. (2017, Diabetes, Obesity and Metabolism) showed that liraglutide reduced appetite ratings and caloric intake but did not eliminate food reward motivation in all participants. More recently, Wharton et al. (2021, Obesity) found that semaglutide users still engaged with preferred foods, just in smaller quantities. The medication changes the volume dial on hunger, it does not rewire your food preferences from scratch. Craving sushi on a GLP-1 is not a red flag. It is expected.

What did they get wrong (or right)?

There is nothing factually wrong here because there are barely any facts stated. The creator does not claim GLP-1s suppress all cravings. They do not claim the drugs are dangerous or miraculous. They are just hungry and making a call. Credit where it is due: the video inadvertently normalizes the experience of still wanting food on GLP-1 therapy, which is something a lot of patients actually need to hear.

The risk is in what the video omits. For someone newly started on semaglutide or tirzepatide who interprets "treat yourself" as a green light to ignore dietary structure, that could work against their goals. GLP-1 therapy is most effective when paired with intentional eating habits, not as a permission slip for unlimited indulgence. That nuance is not present here, and with 183K views, the gap matters.

What should you actually know?

GLP-1 medications reduce hunger signals, but they work best when patients are also building sustainable eating habits around the reduced appetite window they create. "Treat yourself" moments are not inherently problems. Portion size, frequency, and food quality still matter, especially because GLP-1-induced satiety can be unpredictable and varies between patients.

A few things worth knowing if you are on one of these medications:

• Food cravings do not disappear completely for most patients. Research from Rubino et al. (2021, JAMA) on semaglutide 2.4mg showed meaningful weight loss, but participants were still counseled on diet and activity, the medication alone was not the full protocol.
• High-fat meals can worsen GI side effects common to GLP-1 therapy, including nausea and delayed gastric emptying. A cheesy burrito is not off-limits, but timing and portion size matter more than people expect.
• "Treat yourself" culture and GLP-1 therapy can coexist, but patients should talk to their prescribing provider about what dietary flexibility looks like for their specific situation.

The bottom line

This video is not making dangerous medical claims. It is a slice-of-life food moment that landed in the GLP-1 category, likely because the creator is on one of these medications. The implicit message that cravings still happen is accurate and underreported. The missing context about how to navigate those cravings intentionally is a real gap for a 183K-view platform. Nothing here needs a retraction, but it does need a conversation a TikTok cannot have.